|
 |
Program
Friday, June 18, 2010
9.00 Welcome address
L. Moretta, R. Gusmano
Session 1 - Chair: A. Dal Canton
9.15 Hematopoietic stem cell transplantation for severe autoimmune diseases
A. Marmont du Haut Champ
9.45 Renal tissue engineering: bridging the gap between stem cells and functional tissue
J. Davies
10.15 Stem cells: one truth or more than one?
G. Remuzzi
10.45 The kidney regeneration: the good, the bad and the ugly
P. Romagnani
11.15 coffee break
P. Murray
12.15 Mesenchymal stem cells in acute kidney injury: a new therapeutic tool?
M. Morigi
12.35 Notch activation regulates the balance between injury and regeneration in glomerular disorders
L. Ballerini
13.00 Discussion
13.15 lunch
Session 2 - Chair: J. Davies
Potential role of resident adult stem cells in acute tubular damage
F.P. Schena
Targetting the fate of nephron forming stem cells
S. Vainio
Mouse embryonic stem cells derived mesoderm displays nephrogenic potential and generate functional proximal tubule cells
A. Rak-Raszewska
Evaluation of the expression profile and development potential of mouse kidney stem cells
E.J. Ranghini
16.00 tea break
Protective effect of mesenchymal stromal cells in experimental renal transplantation
T. Rampino
IFN-y dependent inhibition of B cell activation by bone marrow derived mesenchymal stem cells in a murine model of systemic lupus erythematosus
E. Traggiai
17.00 Human amniotic fluid stem cells accelerate recovery of acute kidney injury and prolongs survival in mice
C. Rota
17.10 Transplanted embryonic kidneys develop and contribute to kidney regeneration in a rat model of chronic renal diseases
B. Imberti
17.20 Embryoid body formation of human amniotic fluid stem cells depends on mTOR
A. Valli
17.30 Discussion
18.00 End of session
Saturday, June 19, 2010
Session 3 - Chair: G. Remuzzi
B. Bussolati
9.00 Contribution of human amniotic fluid stem cells to in vitro renal tissue formation depends on mTOR
N. Siegel
9.30 Proteomic profile of adult stem cells
L. Gesualdo
10.00 New synthetic molecules and mesenchymal stem cells for the treatment of acute renal injury
F. Bianchi
10.30 The effect of stem cells administration in a model of chronic renal failure
A. van Koppen
10.50 coffee break
11.20 Exploiting the immunomodulatory effects of mesenchymal stromal cells for the clinical practice
P. Comoli
11.40 Mesenchimal stem cells and chronic uremia: slow intossication or sudden death?
U. Kunter
12.00 Nephrogenic potential of bone marrow-derived mesenchymal stem cells
M. Kuzma-Kuzniarska
12.10 Short and long-term effects of bone marrow mesenchymal stem cells in post-ischemic kidney diseases
C. Alfarano
12.20 Podocyte replacement by bone marrow derived progenitors: of mice and men (and rats)
J. U. Becker
12.30 Long term outcome of a double bone marrow and kidney transplantation in a child with Fanconi anemia
E. Lanino
12.40 A stem cell biology viewpoint on the origin of nephrocalcinosis
F. Mezzabotta
12.50 MSC mitochondrial transfer: a possible protective effect against ADR toxicity in podocytes
A. Magnasco
13.00 Effect of rapamycin on CD133+ progenitor cells from polycystic kidneys
R. Carvalhosa
Discussion
Quality assessment questionnaire and CME Test
Release of certificates of attendance
Closing remarks